Semaglutide

Semaglutide – GLP‑1 Receptor Agonist Research Peptide

Semaglutide is a synthetic GLP‑1 receptor agonist supplied as a laboratory reagent for in‑vitro investigation of glucose regulation, energy balance, and cellular signaling pathways. With its strong affinity for the GLP‑1 receptor, Semaglutide serves as a key model compound in metabolic and endocrine research focused on peptide‑receptor interactions and downstream metabolic effects.

This reagent is produced under controlled laboratory conditions and verified by High‑Performance Liquid Chromatography (HPLC), confirming a purity of ≥99%. Each batch is presented as a stable lyophilized powder, suitable for assay development requiring high accuracy, consistency, and reproducibility. Sealed lyophilizate. Shelf life 24 months from manufacture.

Key Specifications

• Product Name: Semaglutide (GLP‑1 analogue)
• Molecular Formula: C187H291N45O59
• Molecular Weight: ≈4,113.6 Da
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized Powder
• Storage: Store refrigerated; protect from light and moisture
• Use Type: Exclusively for in‑vitro research purposes
• CoA / Test Report: Available upon request

Research Applications

• Serves as a primary reference compound in GLP‑1 receptor signaling studies.
• Examined in in‑vitro research on glucose metabolism and hormonal energy processes.
• Referenced in laboratory work exploring metabolic regulation and endocrine pathways.
• Used as a reagent in studies examining energy balance and weight‑regulation mechanisms at the cellular level.

A batch-specific Certificate of Analysis is available on request and accompanies every order.